Bifunctionality of IL-2, a well-known T cell growth and differentiation factor, reveals itself in stimulating Th1 cells and CTL with anti-tumor activity, but at the same time, serving as a potent activator of Tregs, which inhibits immune-mediated anti-tumor activity [3]. This evidence concerns the gene IL2 and neoplasm.